RevolKa expanding research projects with Daiichi Sankyo

Sendai Japan- Mar 4^th, 2025. RevolKa Ltd., a venture-backed biotech company that provides a game-changing protein engineering technology platform (Norio Hamamatsu, CEO) is pleased to announce the successful completion of a research project with Daiichi Sankyo Co., Ltd. (Hiroyuki Okuzawa, President and COO). This is one of the research projects under the Master service agreement announced on May 28^th, 2024 (https://www.revolka.com/news/english/collab-en/a62). RevolKa delivered high-performance protein candidates using its proprietary Artificial Intelligence (AI)-driven Protein Engineering Platform, aiProtein^®. Following this success, Daiichi Sankyo and RevolKa have already initiated multiple new projects.